Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy

Lung cancer still contributes to nearly one‐quarter cancer‐related deaths in the past decades, despite the rapid development of targeted therapy and immunotherapy in non‐small cell lung cancer (NSCLC). The development and availability of comprehensive genomic profiling make the classification of NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yuan, Zhang, Tao, Xu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706764/
https://www.ncbi.nlm.nih.gov/pubmed/34977873
http://dx.doi.org/10.1002/mco2.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706764/
https://www.ncbi.nlm.nih.gov/pubmed/34977873
http://dx.doi.org/10.1002/mco2.105

Ejemplares similares